Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Construction In Progress : ¥1,325 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Jiuzhou Pharmaceutical Co Construction In Progress?

Zhejiang Jiuzhou Pharmaceutical Co's quarterly construction in progress increased from Sep. 2023 (¥1,011 Mil) to Dec. 2023 (¥1,198 Mil) and increased from Dec. 2023 (¥1,198 Mil) to Mar. 2024 (¥1,325 Mil).

Zhejiang Jiuzhou Pharmaceutical Co's annual construction in progress increased from Dec. 2021 (¥472 Mil) to Dec. 2022 (¥839 Mil) and increased from Dec. 2022 (¥839 Mil) to Dec. 2023 (¥1,198 Mil).

Zhejiang Jiuzhou Pharmaceutical Co Construction In Progress Historical Data

The historical data trend for Zhejiang Jiuzhou Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Jiuzhou Pharmaceutical Co Construction In Progress Chart

Zhejiang Jiuzhou Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

273.78

300.08

471.51

839.25

1,198.29

Zhejiang Jiuzhou Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															927.55	914.50	1,010.72	1,198.29	1,324.55

Zhejiang Jiuzhou Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jiuzhou Pharmaceutical Co Ltd (SHSE:603456) » Definitions » Construction In Progress

Traded in Other Exchanges

N/A

Address

99 Waisha Road, Jiaojiang District, Taizhou, Zhejiang, CHN, 318000

Website

http://www.jiuzhoupharma.com

Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based pharmaceutical manufacturer. The company is primarily engaged in the manufacturing, research, development, and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst, and lithium battery materials. Its active pharmaceutical ingredient offerings include Carbamazepine, Duloxetine, Bezafibrate, Meropenem, Sulphadimethoxine Sodium, Oxcarbazepine, Amprolium, among others. The firm also provides services of new drug contract development and manufacturing organization to the international pharmaceutical giant.

Executives

Sha Yu Jie	Directors, senior managers
Mei Yi Jiang	Director
Li Yuan Qiang	senior management
Yang Nong Gang	senior management
	Directors, senior managers
Huang Min Xia	senior management
Wang Bin	Directors, senior managers
Dai Yun You	senior management
Jiang Zu Lin	Directors, senior managers
Guo Zhen Rong	senior management
Chen Zhi Hong	Directors, senior managers
Xu Jia Jun	Supervisors
Hua Li Rong	Director
Lin Hui Lu	senior management
Zhu Guo Liang	Supervisors

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Headlines

No Headlines